Eluna Family / Sentus BP Master Study

CompletedOBSERVATIONAL
Enrollment

167

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

April 30, 2016

Conditions
BradycardiaHeart Failure
Interventions
DEVICE

Eluna pacemaker family

"New pacemaker generation with new functions, like wandless RF telemetry SafeSync"

DEVICE

Sentus BP lead

over-the-wire (OTW), bipolar (BP), L-shaped (L), 4.8 French left ventricular lead

Trial Locations (17)

2900

Gentofte Hospital, Hellerup

3600

ZOL Genk, Genk

4020

Allgemeines Krankenhaus Linz, Linz

5000

Odense University Hospital, Odense

6700

Cliniques du Sud Luxembourg, Arlon

9000

Aalborg Sygehus, Aalborg

12203

Charité Universitätsmedizin Berlin, CBF: Campus Benjamin Franklin, Berlin

13353

Charité - Universitätsmedizin Berlin, CVK: Campus Virchow-Klinikum, Berlin

17475

Universitätsmedizin Greifswald, Greifswald

32756

Klinikum Lippe, Detmold

44534

St. Marien-Hospital Lünen, Lünen

45122

Universitätsklinikum Essen, Westdeutsches Herzzentrum Essen, Essen

45138

Elisabeth Krankenhaus Essen, Essen

66740

Marienhaus GmbH St. Elisabeth Krankenhaus Saarlouis, Saarlouis

79106

Universitäts-Herzzentrum Freiburg, Freiburg im Breisgau

91054

Universitätsklinikum Erlangen, Medizinische Klinik 2, Erlangen

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

Biotronik SE & Co. KG

INDUSTRY

NCT02059629 - Eluna Family / Sentus BP Master Study | Biotech Hunter | Biotech Hunter